DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cyclin D
Cyclin D
The P16 Status of Tumor Cell Lines Identifies Small Molecule Inhibitors Specific for Cyclin-Dependent Kinase 41
Cyclin-Dependent Kinases and CDK Inhibitors in Virus-Associated Cancers Shaian Tavakolian, Hossein Goudarzi and Ebrahim Faghihloo*
Regulation of P27kip1 and P57kip2 Functions by Natural Polyphenols
Expression of P16 INK4A and P14 ARF in Hematological Malignancies
Proteasome System in the Pathogenesis and Treatment of Squamous Head and Neck Carcinoma
G1 Checkpoint Protein and P53 Abnormalities Occur In
Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest Despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells
P27 As a Transcriptional Regulator: New Roles in Development and Cancer
Proteins Regulating Cyclin Dependent Kinases Cdk4 and Cdk5
By Cyclin D:Cdk4/6 Complexes Results in Active
Targeting Cyclin-Dependent Kinases in Human Cancers: from Small Molecules to Peptide Inhibitors
MEN4 and CDKN1B Mutations 24:10 T195–T208 Thematic Review
Role of P16/MTS1, Cyclin D1 and RB in Primary Oral Cancer and Oral
The Interplay of Proteins Encoded by CDKN1A, CDKN1B, CDKN2A and TP53 in the Prognosis of Breast Cancer
Full Text (PDF)
New Functional Activities for the P21 Family of CDK Inhibitors
Cell Cycle Arrest Through Indirect Transcriptional Repression by P53: I Have a DREAM
Cyclin D Mediates Tolerance of Genome-Doubling in Cancers with Functional P53
Top View
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Targeting the Cyclin-Dependent Kinase 5 in Metastatic Melanoma
Targeting the Cyclin-Dependent Kinases (CDK) 4/6 in Estrogen Receptor-Positive Breast Cancers Richard S
Cyclin D 1 Is a Nuclear Protein Required for Cell Cycle Progression in G1
CCND1 and CDKN1B Polymorphisms and Risk of Breast Cancer
Cyclin D1 in Cancer: a Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma
MYC Oncogene Contributions to Release of Cell Cycle Brakes
P16/P14arf Cell Cycle Regulatory Pathways in Primary Neuroblastoma: P16 Expression Is Associated with Advanced Stage Disease1
Signaling Through Cyclin D-Dependent Kinases
Path to Destruction for a Cell-Division Regulator
Immunohistochemical Analysis of Cyclin A, Cyclin D1 and P53 in Mammary Tumors, Squamous Cell Carcinomas and Basal Cell Tumors of Dogs and Cats
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
P63 Maintains Keratinocyte Proliferative Capacity Through Regulation of Skp2–P130 Levels
The Critical Role of Cyclin D2 in Cell Cycle Progression and Tumorigenicity of Glioblastoma Stem Cells
Landscape of Copy Number Aberrations in Esophageal Squamous Cell Carcinoma from a High Endemic Region of South Africa Jacqueline Brown1*, Andrzej J
A Cell Cycle-Regulated Inhibitor of Cyclin-Dependent Kinases LUDGER HENGST*, VJEKOSLAV DULIC *T, JOYCE M
Cyclin-Dependent Kinase 5 Is Essential for Neuronal Cell Cycle Arrest and Differentiation
Cyclin D1 Expression Is a Major Target of the Camp-Induced Inhibition of Cell Cycle Entry in ®Broblasts
Inhibitors of Mammalian G 1 Cyclin-Dependent Kinases
Cyclin D As a Therapeutic Target in Cancer
Jnks Function As CDK4-Activating Kinases by Phosphorylating CDK4 and P21
Structural Basis of Inhibition of CDK–Cyclin Complexes by INK4 Inhibitors
The Role of P16-Cyclin D/CDK-Prb Pathway in the Tumorigenesis Of
Protein Inhibitor of Activated STAT Xα Depresses Cyclin D and Cyclin D Kinase, and Contributes to the Inhibition of Osteosarcoma Cell Progression
Characterizing CDK8/19 Inhibitors Through a Nfκb-Dependent Cell-Based Assay
Targeting the Cyclin D–CDK4/6 Axis for Cancer Treatment Todd Vanarsdale1, Chris Boshoff2, Kim T
Cyclin D1 and P27KIP1: the Gatekeepers of Dysplasia Mahmoud M
Overexpression of CDKN1B Inhibits Fibroblast Proliferation in a Rabbit Model of Experimental Glaucoma Filtration Surgery
Cyclin D Primer Set (P8842)
The P16-Cyclin D1/CDK4-Prb Pathway and Clinical Outcome in Epithelial Ovarian Cancer1